TABLE 4.
Blueberry (n = 26) | Placebo (n = 26) | ||||
---|---|---|---|---|---|
Variable | Baseline2 | 8 wk3 | Baseline2 | 8 wk3 | P 4 |
Total cholesterol, mg/dL | 161.4 ± 9.6 | 155.8 ± 3.8 | 166.4 ± 9.6 | 161.2 ± 7.3 | 0.51 |
LDL cholesterol, mg/dL | 82.8 ± 7.8 | 84.2 ± 5.0 | 87.2 ± 8.4 | 83.2 ± 9.6 | 0.93 |
HDL cholesterol, mg/dL | 44.7 ± 1.9 | 47.1 ± 1.2 | 48.6 ± 2.6 | 44.1 ± 2.2 | 0.25 |
Triglycerides, mg/dL | 186.1 ± 24.6 | 179.6 ± 10.1 | 176.4 ± 15.3 | 199.6 ± 19.9 | 0.03 |
CRP, mg/dL | 0.57 ± 0.1 | 0.50 ± 0.1 | 0.51 ± 0.1 | 0.50 ± 0.1 | 0.99 |
Lipid-lowering medication users5 | |||||
Total cholesterol, mg/dL | 164.2 ± 6.9 | 148.8 ± 4.9 | 164.3 ± 10.6 | 163.6 ± 3.4 | 0.03 |
LDL cholesterol, mg/dL | 102.9 ± 19.7 | 77.2 ± 6.5 | 95.7 ± 40.7 | 84.1 ± 5.4 | 0.04 |
HDL cholesterol, mg/dL | 46.4 ± 2.6 | 44.9 ± 1.5 | 50.3 ± 2.8 | 45.6 ± 1.3 | 0.74 |
Triglycerides, mg/dL | 166.9 ± 24.7 | 160.6 ± 13.1 | 164.5 ± 12.1 | 183.9 ± 10.7 | 0.03 |
CRP, mg/dL | 0.51 ± 0.1 | 0.56 ± 0.1 | 0.52 ± 0.2 | 0.54 ± 0.1 | 0.86 |
CRP, C-reactive protein.
Values are arithmetic means ± SEs from samples collected before the dietary intervention (preintervention values).
Values are least-squares means ± SEs (adjusted for the baseline values) from a linear mixed-model ANOVA that included covariates of age, baseline (preintervention values), BMI, and weight.
Values are for the blueberry and placebo comparison at 8 wk.
n = 17, blueberry lipid-lowering medication users; n = 23, placebo lipid-lowering medication users.